Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
Winnie Chua(University of Birmingham), Larissa Fabritz(University of Birmingham), Gregory Y.H. Lip(Medical University of Białystok), Mark R. Thomas(University of Leeds), Paulus Kirchhof(Universität Hamburg), Samantha Tull(University of Birmingham), Victor Roth Cardoso(University of Birmingham), Georgios V. Gkoutos(University Hospitals Birmingham NHS Foundation Trust), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Yanish Purmah(University of Birmingham), G Neculau(University Hospitals Birmingham NHS Foundation Trust)
Cited by 147
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k